Company Fact Sheet

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: serious infectious disease care, acute cardiovascular care and surgery and perioperative care. The Company operates in the Americas, Europe and the Middle East and Asia Pacific regions with global centers today in Parsippany, N.J. and Zurich.

For a comprehensive overview of the company view our annual report.  

Our History and Values

The Company was founded in 1996 and is publicly traded on the Nasdaq exchange under the ticker symbol MDCO.

At The Medicines Company we are committed to a culture of honesty, integrity and accountability and we apply these principles in our everyday business activities. We provide products and knowledge that directly impact the survival and well-being of people who are critically ill with conditions such as heart attacks, life threatening infections, surgery and trauma. 

There is no higher priority for us than improving health outcomes for patients in cost effective ways. When delivering authentic healthcare innovation, we maintain the highest standards of moral, ethical and professional conduct.

Global Centers

  • North America
    8 Sylvan Way
    Parsippany, NJ 07054 USA
  • Europe
    Talstraße 59 CH-8001
    Zürich Switzerland

Approximately 450 employees (as of July 2016)

The Company is led by our Chief Executive Officer, Clive A. Meanwell, MD, PhD, and a multidisciplinary team with significant experience in pharmaceutical product development and commercialization.

U.S. Marketed Products
View our U.S. marketed products.

Globally Marketed Products
View our globally marketed products.

The Medicines Company has a pipeline of products in development that span across three areas of care Cardiovascular Care, Infectious Disease Care, and Surgery & Perioperative Care.

Product Portfolio
View our full product portfolio.


Media Contact